日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy

来自 SCRUM-MONSTAR GOZILA 子研究的循环肿瘤 DNA 分析在晚期食管鳞状细胞癌中的预后生物标志物和免疫治疗意义

Duan, Yuqing; Hashimoto, Tadayoshi; Shibuki, Taro; Taniguchi, Hiroya; Sunakawa, Yu; Komatsu, Yoshito; Takahashi, Naoki; Sato, Yuta; Yamaguchi, Kensei; Nishina, Tomohiro; Nakanoko, Tomonori; Boku, Shogen; Satoh, Taroh; Yasui, Hisateru; Esaki, Taito; Imai, Mitsuho; Fujisawa, Takao; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer

肿瘤内HER2异质性对HER2阳性胃癌患者曲妥珠单抗疗效的临床影响

Yoshino, Koichiro; Takamatsu, Manabu; Ooki, Akira; Chin, Keisho; Takahari, Daisuke; Osumi, Hiroki; Ogura, Mariko; Tamba, Mikako; Fukuda, Koshiro; Shimozaki, Keitaro; Udagawa, Shohei; Fukuoka, Shota; Shinozaki, Eiji; Yamaguchi, Kensei; Wakatsuki, Takeru

Comparative study of the short-term outcomes of gastric cancer surgery between Japanese Gastric cancer association-certified and non-certified institutions: a retrospective cohort analysis using a national database in Japan

日本胃癌协会认证机构与非认证机构胃癌手术短期疗效的比较研究:基于日本国家数据库的回顾性队列分析

Matsunaga, Tomoyuki; Endo, Hideki; Yamamoto, Hiroyuki; Kumagai, Koshi; Kanaji, Shingo; Kawakami, Hisato; Kusano, Chika; Kushima, Ryoji; Fujishiro, Mitsuhiro; Yamaguchi, Kensei; Yoshikawa, Takaki; Doki, Yuichiro; Kakeji, Yoshihiro; Fujiwara, Yoshiyuki

Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer

基于拷贝数的癌基因优势可能提示 HER2 阳性胃癌中 ERBB2 依赖性和曲妥珠单抗反应

Wakatsuki, Takeru; Yamamoto, Noriko; Ishizuka, Naoki; Hironaka, Shuichi; Minashi, Keiko; Kadowaki, Shigenori; Hirano, Hidekazu; Shoji, Hirokazu; Yamaguchi, Toshifumi; Chin, Keisho; Ogura, Mariko; Nakayama, Izuma; Osumi, Hiroki; Ueki, Arisa; Kitano, Shigehisa; Boku, Narikazu; Yamaguchi, Kensei; Takahari, Daisuke

Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary

纳武利尤单抗联合化疗治疗亚洲晚期或复发性胃癌或胃食管交界处癌患者(ATTRACTION-4 研究):简明语言摘要

Chen, Li-Tzong; Kang, Yoon-Koo; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Chung, Ik-Joo; Yamaguchi, Kensei; Kato, Ken; Sym, Sun Jin; Kadowaki, Shigenori; Tsuji, Kunihiro; Chen, Jen-Shi; Bai, Li-Yuan; Oh, Sung-Yong; Choda, Yasuhiro; Yasui, Hisateru; Takeuchi, Kentaro; Hirashima, Yoshinori; Hagihara, Shunsuke; Boku, Narikazu

Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer

药房门诊随访对维持接受CAPOX辅助化疗的胃癌患者相对剂量强度的重要性

Nakamura, Masashi; Yokokawa, Takashi; Kawakami, Kazuyoshi; Kimura, Yuka; Shimizu, Hisanori; Kobayashi, Kazuo; Aoyama, Takeshi; Suzuki, Wataru; Hatori, Masahiro; Suzuki, Kenichi; Takahari, Daisuke; Ogura, Mariko; Chin, Keisho; Wakatsuki, Takeru; Yamaguchi, Kensei; Yamaguchi, Masakazu

Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

2011年至2023年,HER2阳性晚期胃癌患者的真实世界治疗选择增加,生存率提高。

Shimozaki, Keitaro; Ooki, Akira; Yoshikawa, Kaoru; Yoshino, Koichiro; Udagawa, Shohei; Osumi, Hiroki; Fukuoka, Shota; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

纳武利尤单抗联合化疗或伊匹木单抗治疗胃食管癌:一项随机3期试验的探索性生物标志物分析

Shitara, Kohei; Janjigian, Yelena Y; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yañez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming

Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors

晚期胃肠道肿瘤中基于循环肿瘤DNA分析的靶向治疗

Nakamura, Yoshiaki; Ozaki, Hiroshi; Ueno, Makoto; Komatsu, Yoshito; Yuki, Satoshi; Esaki, Taito; Taniguchi, Hiroya; Sunakawa, Yu; Yamaguchi, Kensei; Kato, Ken; Denda, Tadamichi; Nishina, Tomohiro; Takahashi, Naoki; Satoh, Taroh; Yasui, Hisateru; Satake, Hironaga; Oki, Eiji; Kato, Takeshi; Ohta, Takashi; Matsuhashi, Nobuhisa; Goto, Masahiro; Okano, Naohiro; Ohtsubo, Koushiro; Yamazaki, Kentaro; Yamashita, Riu; Iida, Naoko; Yuasa, Mihoko; Bando, Hideaki; Yoshino, Takayuki

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

在无法切除的局部晚期食管鳞状细胞癌患者中,接受根治性放化疗后使用阿特珠单抗治疗——一项多中心 2 期试验 (EPOC1802)

Bando Hideaki, Kumagai Shogo, Kotani Daisuke, Mishima Saori, Irie Takuma, Itahashi Kota, Tanaka Yosuke, Habu Takumi, Fukaya Sayuri, Kondo Masaki, Tsushima Takahiro, Hara Hiroki, Kadowaki Shigenori, Kato Ken, Chin Keisho, Yamaguchi Kensei, Kageyama Shun-Ichiro, Hojo Hidehiro, Nakamura Masaki, Tachibana Hidenobu, Wakabayashi Masashi, Fukui Makoto, Fuse Nozomu, Koyama Shohei, Mano Hiroyuki, Nishikawa Hiroyoshi, Shitara Kohei, Yoshino Takayuki, Kojima Takashi